sd biosensor v2 Search Results


sd biosensor v1 assay  (SD Biosensor)
90
SD Biosensor sd biosensor v1 assay
Serological responses to a single dose of the AstraZeneca vaccine according to the number of days after vaccination. (A) Roche; (B) Abbott; (C) Siemens; (D) <t>SD</t> <t>Biosensor</t> <t>V1;</t> (E) SD Biosensor V2; (F) GenScript. P values were calculated by the Mann-Whitney U test for the quantitative differences between 11 and 20 days and 21 to 28 days after the first vaccination. Chi-square tests were applied to the calculation of P values for the qualitative rates of positivity. The difference between baseline and the first vaccination was significant in all assays included ( P < 0.001). Dashed lines indicate the cutoff of each assay.
Sd Biosensor V1 Assay, supplied by SD Biosensor, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sd biosensor v1 assay/product/SD Biosensor
Average 90 stars, based on 1 article reviews
sd biosensor v1 assay - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
sd biosensor v1 versus sd biosensor v2  (SD Biosensor)
90
SD Biosensor sd biosensor v1 versus sd biosensor v2
Serological responses to a single dose of the AstraZeneca vaccine according to the number of days after vaccination. (A) Roche; (B) Abbott; (C) Siemens; (D) <t>SD</t> <t>Biosensor</t> <t>V1;</t> (E) SD Biosensor V2; (F) GenScript. P values were calculated by the Mann-Whitney U test for the quantitative differences between 11 and 20 days and 21 to 28 days after the first vaccination. Chi-square tests were applied to the calculation of P values for the qualitative rates of positivity. The difference between baseline and the first vaccination was significant in all assays included ( P < 0.001). Dashed lines indicate the cutoff of each assay.
Sd Biosensor V1 Versus Sd Biosensor V2, supplied by SD Biosensor, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sd biosensor v1 versus sd biosensor v2/product/SD Biosensor
Average 90 stars, based on 1 article reviews
sd biosensor v1 versus sd biosensor v2 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Serological responses to a single dose of the AstraZeneca vaccine according to the number of days after vaccination. (A) Roche; (B) Abbott; (C) Siemens; (D) SD Biosensor V1; (E) SD Biosensor V2; (F) GenScript. P values were calculated by the Mann-Whitney U test for the quantitative differences between 11 and 20 days and 21 to 28 days after the first vaccination. Chi-square tests were applied to the calculation of P values for the qualitative rates of positivity. The difference between baseline and the first vaccination was significant in all assays included ( P < 0.001). Dashed lines indicate the cutoff of each assay.

Journal: Journal of Clinical Microbiology

Article Title: Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers

doi: 10.1128/JCM.01105-21

Figure Lengend Snippet: Serological responses to a single dose of the AstraZeneca vaccine according to the number of days after vaccination. (A) Roche; (B) Abbott; (C) Siemens; (D) SD Biosensor V1; (E) SD Biosensor V2; (F) GenScript. P values were calculated by the Mann-Whitney U test for the quantitative differences between 11 and 20 days and 21 to 28 days after the first vaccination. Chi-square tests were applied to the calculation of P values for the qualitative rates of positivity. The difference between baseline and the first vaccination was significant in all assays included ( P < 0.001). Dashed lines indicate the cutoff of each assay.

Article Snippet: The SD Biosensor V2 assay, targeting the antibody to the South Africa/Brazil variant of SARS-CoV-2, showed 72.2% positivity, whereas the SD Biosensor V1 assay, targeting the antibody to the original Wuhan SARS-CoV-2 and UK variant, revealed 90.7% positivity.

Techniques: MANN-WHITNEY

Comparison of serological responses to a single dose of the AstraZeneca vaccine according to adverse reactions. Shown are quantitative values related to the severity of adverse reactions for the Roche (A), Abbott (B), Siemens (C), SD Biosensor V1 (D), SD Biosensor V2 (E), and GenScript (F) assays and the quantitative assay values according to the duration of adverse reactions for the Roche (G), Abbott (H), Siemens (I), SD Biosensor V1 (J), SD Biosensor V2 (K), and GenScript (L) assays. P values were calculated by the Kruskal-Wallis test for the quantitative differences among <1 day, 2 to 3 days, and >4 days after the first vaccination. Chi-square tests were used for the calculation of P values for the qualitative rates of positivity. Dashed lines show the cutoff of each assay.

Journal: Journal of Clinical Microbiology

Article Title: Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers

doi: 10.1128/JCM.01105-21

Figure Lengend Snippet: Comparison of serological responses to a single dose of the AstraZeneca vaccine according to adverse reactions. Shown are quantitative values related to the severity of adverse reactions for the Roche (A), Abbott (B), Siemens (C), SD Biosensor V1 (D), SD Biosensor V2 (E), and GenScript (F) assays and the quantitative assay values according to the duration of adverse reactions for the Roche (G), Abbott (H), Siemens (I), SD Biosensor V1 (J), SD Biosensor V2 (K), and GenScript (L) assays. P values were calculated by the Kruskal-Wallis test for the quantitative differences among <1 day, 2 to 3 days, and >4 days after the first vaccination. Chi-square tests were used for the calculation of P values for the qualitative rates of positivity. Dashed lines show the cutoff of each assay.

Article Snippet: The SD Biosensor V2 assay, targeting the antibody to the South Africa/Brazil variant of SARS-CoV-2, showed 72.2% positivity, whereas the SD Biosensor V1 assay, targeting the antibody to the original Wuhan SARS-CoV-2 and UK variant, revealed 90.7% positivity.

Techniques:

Correlation plots with ρ values of five SARS-CoV-2 antibody assays. (A) Abbott versus Roche; (B) Abbott versus Siemens; (C) Roche versus Siemens; (D) SD Biosensor V1 versus SD Biosensor V2; (E) SD Biosensor V1 versus GenScript; (F) SD Biosensor V2 versus GenScript.

Journal: Journal of Clinical Microbiology

Article Title: Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers

doi: 10.1128/JCM.01105-21

Figure Lengend Snippet: Correlation plots with ρ values of five SARS-CoV-2 antibody assays. (A) Abbott versus Roche; (B) Abbott versus Siemens; (C) Roche versus Siemens; (D) SD Biosensor V1 versus SD Biosensor V2; (E) SD Biosensor V1 versus GenScript; (F) SD Biosensor V2 versus GenScript.

Article Snippet: The SD Biosensor V2 assay, targeting the antibody to the South Africa/Brazil variant of SARS-CoV-2, showed 72.2% positivity, whereas the SD Biosensor V1 assay, targeting the antibody to the original Wuhan SARS-CoV-2 and UK variant, revealed 90.7% positivity.

Techniques:

Analysis of discrepant results among five SARS-CoV-2 antibody assays before and after the 1st dose of the AstraZeneca vaccine <xref ref-type= a " width="100%" height="100%">

Journal: Journal of Clinical Microbiology

Article Title: Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers

doi: 10.1128/JCM.01105-21

Figure Lengend Snippet: Analysis of discrepant results among five SARS-CoV-2 antibody assays before and after the 1st dose of the AstraZeneca vaccine a

Article Snippet: The SD Biosensor V2 assay, targeting the antibody to the South Africa/Brazil variant of SARS-CoV-2, showed 72.2% positivity, whereas the SD Biosensor V1 assay, targeting the antibody to the original Wuhan SARS-CoV-2 and UK variant, revealed 90.7% positivity.

Techniques: